» Articles » PMID: 12512647

What is Nonablative Photorejuvenation of Human Skin?

Overview
Date 2003 Jan 7
PMID 12512647
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Nonablative photorejuvenation has become an integral procedure in the emerging discipline of laser dermatologic surgery. The objective is to confine selectively, without any epidermal damage, thermal injury to the papillary, and upper reticular dermis leading to fibroblast activation and synthesis of new collagen and extracellular matrix material. The procedure results in minimal patient morbidity, no interference with lifestyle, and a low risk of complications, while providing a satisfying degree of rhytides reduction. Multiple devices have been studied and marketed for nonablative photorejuvenation of human skin. However, currently, nonablative photorejuvenation should not be considered an alternative to laser skin resurfacing. The skin surface is not removed or modified. What really occurs may be more accurately referred to as dermal "remodeling" or "toning" as a wound healing response is initiated and collagen regenerated. The narrow "therapeutic window" of laser-induced dermal heating and epidermal cooling must still be optimized so that effective treatments can be obtained routinely. Clinical verification of effective treatment parameters (irradiation wavelength, pulse structure, radiant exposure, cooling time) will be obtained through further human studies. Most importantly, understanding the relationship between the degree of dermal thermal injury and synthesis of new collagen and extracellular matrix material will be fundamental to predicting the clinical efficacy and limitations of nonablative photorejuvenation.

Citing Articles

Clinical evaluation of the efficacy and safety of combined bipolar radiofrequency and optical energies vs. optical energy alone for the treatment of aging hands.

Verner I, Kutscher T Lasers Med Sci. 2017; 32(6):1387-1392.

PMID: 28643046 DOI: 10.1007/s10103-017-2257-z.


A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation.

Nikolis A, Bernstein S, Kinney B, Scuderi N, Rastogi S, Sampalis J Clin Cosmet Investig Dermatol. 2016; 9:115-25.

PMID: 27257391 PMC: 4874553. DOI: 10.2147/CCID.S100697.


Objective assessment of intensive targeted treatment for solar lentigines using intense pulsed light with wavelengths between 500 and 635 nm.

Tanaka Y, Tsunemi Y, Kawashima M Lasers Surg Med. 2015; 48(1):30-5.

PMID: 26462982 PMC: 5396364. DOI: 10.1002/lsm.22433.


Treating cutaneous aging with patented technologies.

Lai W, Lin M J Biosci. 2015; 40(2):209-16.

PMID: 25963249 DOI: 10.1007/s12038-015-9522-8.


The aesthetic applications of intense pulsed light using the Lumenis M-22 device.

Ullmann Y, Elkhatib R, Fodor L Laser Ther. 2013; 20(1):23-8.

PMID: 24155509 PMC: 3806078. DOI: 10.5978/islsm.20.23.